Cargando…

Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer

BACKGROUND: Colorectal cancer (CRC) is one of the most common malignant neoplasms worldwide. Although marker genes associated with CRC have been identified previously, only a few have fulfilled the therapeutic demand. Therefore, based on differentially expressed genes (DEGs), this study aimed to est...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Di, Liufu, Junye, Yang, Qiyuan, Dai, Shengqun, Wang, Jiaqi, Xie, Biao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628086/ https://www.ncbi.nlm.nih.gov/pubmed/36319976 http://dx.doi.org/10.1186/s13062-022-00342-w

Ejemplares similares

Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma
por: Fan, Xiaoyan, et al.
Publicado: (2022)

Identification of a Novel Five-Gene Signature as a Prognostic and Diagnostic Biomarker in Colorectal Cancers
por: Ghatak, Souvik, et al.
Publicado: (2022)

Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021)

Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma
por: Wang, Jihan, et al.
Publicado: (2021)

Meta-signature LncRNAs serve as novel biomarkers for colorectal cancer: integrated bioinformatics analysis, experimental validation and diagnostic evaluation
por: Dai, Meiyu, et al.
Publicado: (2017)

Identification of the 3-lncRNA Signature as a Prognostic Biomarker for Colorectal Cancer
por: Liu, Shuzhen, et al.
Publicado: (2020)

Identification of a prognostic signature and ENTR1 as a prognostic biomarker for colorectal mucinous adenocarcinoma
por: Huang, An, et al.
Publicado: (2023)

Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer
por: Ahluwalia, Pankaj, et al.
Publicado: (2019)

Identification and in vitro validation of diagnostic and prognostic biomarkers for lung squamous cell carcinoma
por: Zhao, Xiaopeng, et al.
Publicado: (2022)

A serum piRNA signature as promising non-invasive diagnostic and prognostic biomarkers for colorectal cancer
por: Qu, Ailin, et al.
Publicado: (2019)

Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer
por: Li, Shuwei, et al.
Publicado: (2017)

Identification of Potential Diagnostic and Prognostic Biomarkers for Colorectal Cancer Based on GEO and TCGA Databases
por: Wang, Zhenjiang, et al.
Publicado: (2021)

Identification and validation of m6A-GPI signatures as a novel prognostic model for colorectal cancer
por: Ma, Bin, et al.
Publicado: (2023)

Identification of the miRNA signature and key genes in colorectal cancer lymph node metastasis
por: Wang, Xi, et al.
Publicado: (2021)

Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma
por: Xiao, Kai, et al.
Publicado: (2020)

Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma
por: Chen, Wenbiao, et al.
Publicado: (2020)

LncRNA ARST is a Novel Prognostic and Diagnostic Biomarker for Colorectal Cancer
por: Dong, Lujia, et al.
Publicado: (2022)

Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer
por: Jayaraman, Muralidharan, et al.
Publicado: (2017)

Novel diagnostic and prognostic biomarkers of colorectal cancer: Capable to overcome the heterogeneity-specific barrier and valid for global applications
por: Hameed, Yasir, et al.
Publicado: (2021)

Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma
por: Li, Ran, et al.
Publicado: (2020)

Identification and Validation of Prognostically Relevant Gene Signature in Melanoma
por: Gao, Yali, et al.
Publicado: (2020)

Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer
por: Cheng, Lin, et al.
Publicado: (2021)

Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis
por: Rahman, Md. Rezanur, et al.
Publicado: (2019)

Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer
por: Liu, Jiaxin, et al.
Publicado: (2022)

Construction and validation of a novel apoptosis-associated prognostic signature related to osteosarcoma metastasis and immune infiltration
por: Fu, Yucheng, et al.
Publicado: (2022)

Genome-Wide Identification of a Novel Autophagy-Related Signature for Colorectal Cancer
por: Huang, Zhi, et al.
Publicado: (2019)

Identification and validation of prognosis-associated DNA repair gene signatures in colorectal cancer
por: Song, Dingli, et al.
Publicado: (2022)

Identification and Validation of a Prognostic Signature Based on Methylation Profiles and Methylation-Driven Gene DAB2 as a Prognostic Biomarker in Differentiated Thyroid Carcinoma
por: Ju, Gaoda, et al.
Publicado: (2022)

Identification of novel diagnostic biomarkers for thyroid carcinoma
por: Wang, Xiliang, et al.
Publicado: (2017)

Identification and validation of DLX4 as a prognostic and diagnostic biomarker for clear cell renal cell carcinoma
por: Wang, Jiawei, et al.
Publicado: (2023)

Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma
por: Cheng, Yang, et al.
Publicado: (2019)

Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer
por: Wang, Qian-Qian, et al.
Publicado: (2022)

Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
por: Hua, Shan, et al.
Publicado: (2022)

Derivation and Clinical Validation of a Redox-Driven Prognostic Signature for Colorectal Cancer
por: Dang, Qin, et al.
Publicado: (2021)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Identification and validation of immune‐related lncRNA prognostic signatures for melanoma
por: Xiao, Bo, et al.
Publicado: (2021)

Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer
por: Pei, Jianying, et al.
Publicado: (2020)

Identification and Validation of Novel Serum Autoantibody Biomarkers for Early Detection of Colorectal Cancer and Advanced Adenoma
por: Wang, Hejing, et al.
Publicado: (2020)

Identification of a Nine Immune-Related lncRNA Signature as a Novel Diagnostic Biomarker for Hepatocellular Carcinoma
por: Yuan, Mengqin, et al.
Publicado: (2021)

Development and validation of a prognostic 9-gene signature for colorectal cancer
por: Cui, Junpeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sm2gev4lf2g76e52l3e9sftmk2